MAPT and Alzheimer disease: This suggests that both Aβ and tau may independently contribute to the perception of a cognitive decline, and that concurrent endorsement of multiple SCD‐plus features was a robust indicator of abnormal AD biomarkers in CU older adults (both Aβ and tau), whereas isolated SCD‐plus features were most sensitive for Aβ biomarkers.